Breakdown | TTM | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 | Dec 2020 |
---|---|---|---|---|---|---|
Income Statement | ||||||
Total Revenue | 85.54M | 81.00M | 86.98M | 73.33M | 112.80M | 52.33M |
Gross Profit | 50.92M | 44.02M | 54.53M | 39.70M | 68.19M | 19.35M |
EBITDA | 44.75M | 48.38M | 53.84M | 31.94M | 64.67M | 8.73M |
Net Income | 26.27M | 22.22M | 27.50M | 10.76M | 38.22M | -26.74M |
Balance Sheet | ||||||
Total Assets | 85.34M | 333.57M | 318.28M | 326.40M | 349.76M | 334.79M |
Cash, Cash Equivalents and Short-Term Investments | 10.21M | 80.05M | 63.04M | 74.97M | 97.74M | 88.47M |
Total Debt | 0.00 | 1.45M | 1.75M | 13.91M | 4.16M | 7.64M |
Total Liabilities | 82.19M | 59.47M | 63.91M | 93.33M | 95.88M | 103.19M |
Stockholders Equity | 3.14M | 274.10M | 254.37M | 233.07M | 253.88M | 231.61M |
Cash Flow | ||||||
Free Cash Flow | 14.65M | 20.06M | 8.42M | 1.07M | 22.55M | 4.50M |
Operating Cash Flow | 20.20M | 30.82M | 12.54M | 1.16M | 30.14M | 9.23M |
Investing Cash Flow | -5.23M | -10.74M | -3.79M | -13.74M | 10.19M | -4.72M |
Financing Cash Flow | -11.43M | -2.10M | -19.68M | -5.84M | -33.37M | -9.41M |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
---|---|---|---|---|---|---|---|
72 Outperform | $2.80B | 16.44 | 8.41% | ― | -7.18% | -19.63% | |
60 Neutral | HK$2.48B | 24.39 | 4.16% | 4.00% | 1.09% | ― | |
58 Neutral | HK$29.58B | 73.88 | 2.29% | ― | 24.36% | -18.99% | |
55 Neutral | AU$3.53B | 16.62 | -1.37% | 3.13% | 4.07% | -17.03% | |
52 Neutral | HK$134.38M | ― | -12.77% | ― | -8.19% | -498.76% | |
46 Neutral | HK$580.53M | ― | -20.32% | ― | 27.72% | -117.07% | |
43 Neutral | HK$1.43B | ― | ― | ― | ― |
IMAX China Holding, Inc. has announced a board meeting scheduled for July 24, 2025, to discuss and approve the interim results for the first half of the year ending June 30, 2025. The meeting will also consider the possibility of an interim dividend and address other business matters, indicating a review of the company’s financial performance and potential shareholder returns.
IMAX China Holding, Inc. announced the grant of 473,400 Restricted Share Units (RSUs) to five directors as part of their remuneration package. This grant represents approximately 0.14% of the company’s issued share capital and is valued at around HK$3,896,082. The RSUs, which are exempt from certain reporting and approval requirements, will vest immediately without performance conditions, and a professional trustee will manage the administration and vesting process.
IMAX China Holding, Inc. held its Annual General Meeting on June 12, 2025, where all proposed resolutions were passed. Key resolutions included the re-election of directors, authorization for directors to fix remuneration, reappointment of auditors, and mandates for share buybacks and issuance. These decisions reflect a strategic focus on maintaining strong governance and operational flexibility, potentially enhancing shareholder value.
IMAX China Holding, Inc. has announced its Annual General Meeting scheduled for June 12, 2025, in Shanghai, China. Key agenda items include the re-election of three non-executive directors, the re-appointment of PricewaterhouseCoopers as auditors, and the authorization for the company to buy back shares and issue additional shares. These resolutions aim to strengthen the company’s governance and provide flexibility in capital management, potentially impacting its market positioning and shareholder value.
IMAX China Holding, Inc. announced that its controlling shareholder, IMAX Corporation, released its first quarter 2025 financial results and quarterly report. The financial information, prepared according to U.S. Generally Accepted Accounting Principles, is not directly comparable to IMAX China’s financial results reported under International Financial Reporting Standards. This announcement ensures that all shareholders and potential investors have equal access to the company’s financial information, providing transparency and maintaining compliance with disclosure obligations.
IMAX China Holding, Inc. has announced significant changes in its board of directors, effective April 23, 2025. Jim Athanasopoulos has resigned as an executive director and authorized representative to focus on his role at IMAX Corporation, while Daniel Wade Manwaring has been appointed as the new authorized representative. Additionally, Jiande Chen has been redesignated from an executive director to a non-executive director, and Natasha Fernandes has been appointed as a non-executive director. These changes reflect a strategic realignment within the company’s leadership, potentially impacting its strategic direction and stakeholder relations.
IMAX China Holding, Inc. has announced a new composition of its board of directors, effective April 23, 2025, with Richard Gelfond as Chairman and Daniel Manwaring as Executive Director. This restructuring of the board, which includes a mix of executive, non-executive, and independent directors, is likely to influence the company’s strategic direction and governance, potentially impacting its market positioning and stakeholder relations.